Conditional survival in patients with thyroid cancer

Thyroid

Volumn 24, Issue 12, 2014, Pages 1784-1789

  Banerjee, Mousumi ^a   Muenz, Daniel G ^a   Worden, Francis P ^b   Wong, Sandra L ^b   Haymart, Megan R ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; THYROID CANCER; VERY ELDERLY; ADENOCARCINOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; THYROID TUMOR;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SEX FACTORS; SURVIVAL RATE; THYROID NEOPLASMS;

EID: 84918504413     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2014.0264     Document Type: Article

References (20)

1. Davies L, Welch HG. (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167
2. Chen AY, Jemal A, Ward EM. (2009). Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115: 3801-3807
3. www.seer.cancer.gov 2013 (accessed November 1, 2013
4. Simard EP, Ward EM, Siegel R, Jemal A. (2012). Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. (2012). Jan 4 [Epub ahead of print]; DOI: 10.3322/caac.20141
5. Esserman LJ, Thompson IM Jr, Reid B. (2013). Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA 310: 797-798
6. Davies L, Welch HG. (2014). Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140: 317-322
7. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. (1998). A National Cancer Data Base report on 53, 856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see comments]. Cancer 83: 2638-2648
8. Jonklaas J, Sarlis NJ, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis M, Maxon HR, Sherman SI. (2006). Outcomes of patients with differentiated thyroid carcinoma following initial therapy. Thyroid 16: 1229-1242
9. Gilliland FD, Hunt WC, Morris DM, Key CR. (1997). Prognostic factors for thyroid carcinoma. A population-based study of 15, 698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79: 564-573
10. Janssen-Heijnen ML, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, Coebergh JW. (2010). Clinical relevance of conditional survival of cancer patients in Europe: age-specific analyses of 13 cancers. J Clin Oncol 28: 2520-2528
11. Verburg FA, Mader U, Tanase K, Thies ED, Diessl S, Buck AK, Luster M, Reiners C. (2013). Life expectancy is reduced in differentiated thyroid cancer patients 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab 98: 172-180
12. Yang L, Shen W, Sakamoto N. (2013). Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer. J Clin Oncol 31: 468-474
13. Merrill RM, Hunter BD. (2010). Conditional survival among cancer patients in the United States. Oncologist 15: 873-882
14. Merrill RM, Henson DE, Barnes M. (1999). Conditional survival among patients with carcinoma of the lung. Chest 116: 697-703
15. Bouvier AM, Remontet L, Hé delin G, Launoy G, Jooste V, Grosclaude P, Belot A, Lacour B, Estève J, Bossard N, Faivre J; Association of the French Cancer Registries (FRANCIM) 2009 Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis. Cancer 115: 4616-4624
16. American Cancer Society. (2013). www.cancer.org (accessed July 2, 2013
17. Johnston LE, Tran Cao HS, Chang DC, Bouvet M. (2012). Sociodemographic predictors of survival in differentiated thyroid cancer: results from the SEER Database. ISRN Endocrinol 2012: 384707
18. Jonklaas J, Nogueras-Gonzalez G, Munsell M, Litofsky D, Ain KB, Bigos ST, Brierley JD, Cooper DS, Haugen BR, Ladenson PW, Magner J, Robbins J, Ross DS, Skarulis MC, Steward DL, Maxon HR, Sherman SI. (2012). The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab 97: E878-887
19. Vini L, Hyer SL, Marshall J, A'Hern R, Harmer C. (2003). Long-Term results in elderly patients with differentiated thyroid carcinoma. Cancer 97: 2736-2742
20. Hoel DG, Ron E, Carter R, Mabuchi K. (1993). Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst 85: 1063-1068